Marina Mylnarsky is a strategic and visionary finance leader currently serving as the Senior Director of HOCT Portfolio Finance at Bristol-Myers Squibb, where they manage $1.5 billion in annual spend and drive financial excellence across the R&D portfolio. Previously, Marina held various finance roles within Bristol-Myers Squibb, focusing on oncology and virology, while also contributing to internal audits at IDT and Ernst & Young. They earned their Bachelor's Degree in Accounting with High Honors from Rutgers University. Marina is passionate about optimizing portfolio investments and fostering financial transparency to support drug development and enterprise growth.
Location
Marlboro, United States
This person is not in any teams
This person is not in any offices